DAMORA THERAPEUTICS, INC. Property, Plant and Equipment, Additions
DAMORA THERAPEUTICS, INC. (DMRA) reported Property, Plant and Equipment, Additions of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2022-02-17.
Discontinued › Notes
us-gaap:PropertyPlantAndEquipmentAdditions · last filed 2022-02-17
- DAMORA THERAPEUTICS, INC. property, plant and equipment, additions for fiscal 2020 was $0.00.
| Period end | Property, Plant and Equipment, Additions 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2022-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |